# Christopher Bissonnette

> Christopher Bissonnette is a seed investor at Creative Destruction Lab backing Software. See 8 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Creative Destruction Lab](https://shizune.co/investors/profile/creative-destruction-lab)
- Location: Chicago, United States
- Total investments: 8
- Last investment: Dec 2023
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/christopher-bissonnette/

Christopher Bissonnette is a seed investor at Creative Destruction Lab in Chicago focused on Software and Enterprise Software. Christopher Bissonnette is the President at Pallasite Ventures. Whether it’s as a neuroscientist researching Alzheimer disease therapies, or as an executive in control of investment portfolios and commercial real estate, Christopher has taken an analytical approach throughout his career. This varied experience has given him valuable insightinto Chicago’s most desirable locations for advertisers and a deep understanding of the complex leasing and permitting restrictions involved. As co-founder and CFO of GreenSigns Chicago, Christopher helps ensure that our advertisers and landlords receive the best possible value. As an avid biker and hiker, he helps ensure a high-energy level throughout the GreenSigns’ office.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $653k–$5M |
| Series A | $15M–$20M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 2 | 25% |
| Enterprise Software | 2 | 25% |
| Information Technology | 2 | 25% |
| CRM | 1 | 13% |
| Video | 1 | 13% |

27 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 5 | 63% |
| Series A | 1 | 13% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Canada | 4 | 50% |
| United States | 1 | 13% |
| United Kingdom | 1 | 13% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Ionomr | Ionomr is pioneering and commercializing the world's most advanced ion-exchange materials. These provide an enabling platform for clean tech solutions after more than five decades of stagnation in available materials. Using our deep knowledge of scalable electrochemical systems, we enable more efficient systems that will lead to thedecarbonization of the planet for future generations. To date, electrochemical applications in the clean tech realm use materials that contain toxic fluorinated chemicals (PFCs). PFCs leach into water sources and bioaccumulate for hundreds of years, having a dire impact on human health and the entire ecosystem. We are driven to replace these materials with our environmentally friendly hydrocarbon alternatives that reduce pollution at the source, and are proven to be more durable and efficient than incumbent materials. Ionomr's membranes and polymers are highly processable, which allow for simple integration into electrochemical systems. We enable optimal performance in applications for chemical & water remediation, energy storage and hydrogen. We are passionate about empowering the development of resilient and sustainable systems that will underlie the future of the renewable energy and circular chemical economies. | $20M | Series A | Dec 05, 2023 |  |
| Ionomr | Ionomr is pioneering and commercializing the world's most advanced ion-exchange materials. These provide an enabling platform for clean tech solutions after more than five decades of stagnation in available materials. Using our deep knowledge of scalable electrochemical systems, we enable more efficient systems that will lead to thedecarbonization of the planet for future generations. To date, electrochemical applications in the clean tech realm use materials that contain toxic fluorinated chemicals (PFCs). PFCs leach into water sources and bioaccumulate for hundreds of years, having a dire impact on human health and the entire ecosystem. We are driven to replace these materials with our environmentally friendly hydrocarbon alternatives that reduce pollution at the source, and are proven to be more durable and efficient than incumbent materials. Ionomr's membranes and polymers are highly processable, which allow for simple integration into electrochemical systems. We enable optimal performance in applications for chemical & water remediation, energy storage and hydrogen. We are passionate about empowering the development of resilient and sustainable systems that will underlie the future of the renewable energy and circular chemical economies. | $14.9M | Series A | Jan 19, 2022 |  |
| Phoenix Molecular Designs | Phoenix Molecular Designs is developing precise cancer therapeutics with a platform technology focused on developing first-in-class kinase inhibitors designed to uniquely target p90 ribosomal S6 kinase (RSK). Their world-renowned leadership team boasts over 100 years of oncology experience from notable affiliations such as Genentech, Pfizer and EliLily. The company completed a Phase 1 first-in-human clinical trial with lead asset, PMD-026, as of Oct 2020, treating women with metastatic breast cancer. A Phase 1b mono-therapy trial is now open in triple negative breast cancer (TNBC) in 9 leading medical centers across the United States. | $5M | Seed | Nov 20, 2019 |  |
| Keela | Keela provides accessible productive technology for small and medium-sized nonprofit impact organizations. We develop tools for 95% of the nonprofit market underserved by current technological offerings. Our platform helps nonprofits organize and integrate workflows, which saves them time and money. Keela’s tools includes the ability to manageprojects, contacts, campaigns, and donations. | $1.5M | Seed | Sep 19, 2018 |  |
| Phoenix Molecular Designs | Phoenix Molecular Designs is developing precise cancer therapeutics with a platform technology focused on developing first-in-class kinase inhibitors designed to uniquely target p90 ribosomal S6 kinase (RSK). Their world-renowned leadership team boasts over 100 years of oncology experience from notable affiliations such as Genentech, Pfizer and EliLily. The company completed a Phase 1 first-in-human clinical trial with lead asset, PMD-026, as of Oct 2020, treating women with metastatic breast cancer. A Phase 1b mono-therapy trial is now open in triple negative breast cancer (TNBC) in 9 leading medical centers across the United States. | $2.7M | Seed | Sep 18, 2018 |  |
| Hack Capital Ventures | Hack Capital is a software company that helps digital companies hire, train, retain, and motivate employees to do the best work of their lives. The company is building vertically integrated systems of intelligence that will help startup companies, as they grow, to manage their scale intelligently. | $750K | Seed | Feb 13, 2018 |  |
| ViralGains | ViralGains is a video ad journey platform that enables marketers to engage people with relevant brand stories in the contexts that people most favor. Using the platform to engage in a two-way conversation, brands discover exactly what people want and how they feel and build a unique journey that connects highly qualified consumers with relevantmessages that generate awareness, motivate intent, and impact purchase decisions. ViralGains is headquartered in Boston, with regional offices in Chicago, Detroit, Los Angeles, San Francisco, and New York. | $2.8M | Seed | Jul 31, 2014 |  |
| TradingView | TradingView is a network of traders and investors – powered by real-time data and market-leading analysis software. It’s a word-of-mouth success story: from TechStars in Chicago in 2013, to over 15 million monthly active site users and over 40,000 publishers, brokerages, and fintech utilizing its investing tools. TradingView is a global team ofover 200+, founded by Stan Bokov, Denis Globa, and Constantin Ivanov. In 2018 TradingView completed a $37 million Series B round led by Insight Partners, and in 2019 they acquired TradeIT in order to accelerate the company’s existing vision. | $652.5K | Seed | Jan 08, 2014 |  |

8 of 8 investments shown.

## Co-investors
- [Chevron Technology Ventures](https://shizune.co/investors/profile/chevron-technology-ventures) — VC Fund, 2 deals together
- [Finindus](https://shizune.co/investors/profile/finindus) — VC Fund, 2 deals together
- [Natural Gas Innovation Fund](https://shizune.co/investors/profile/natural-gas-innovation-fund) — VC Fund, 2 deals together
- [Shell Ventures](https://shizune.co/investors/profile/shell-technology-ventures) — VC Fund, 2 deals together
- [Active Impact Investments](https://shizune.co/investors/profile/active-impact-investments) — VC Fund, 1 deal together
- [Asahi Kasei](https://shizune.co/investors/profile/asahi-kasei) — VC Fund, 1 deal together

## About Creative Destruction Lab

VC Fund · Toronto, Canada

Creative Destruction Lab (CDL) is a no-fee/no-equity organization that delivers an objectives-based mentoring program for massively scalable, pre-seed stage, science- and technology-based companies. Its nine-month program allows founders to learn from experienced entrepreneurs, increasing their likelihood of success. Founded in 2012 byProfessor Ajay Agrawal at the University of Toronto’s Rotman School of Management, the program has expanded to thirteen sites across seven countries: Seattle, Oxford, Paris, Atlanta, Estonia, Wisconsin, Vancouver, Calgary, Montreal, Berlin, Melbourne and Halifax.

5 contacts available at Creative Destruction Lab.

| Name | Title | Profile |
| --- | --- | --- |
| Daniel Mulet Lind | Associate Director, Quantum Machine Learning | https://shizune.co/investors/profile/daniel-mulet-lind |
| Dennis Kavelman | Founding Partner and Associate | https://shizune.co/investors/profile/dennis-kavelman |
| Frederic Bastien | Fellow | https://shizune.co/investors/profile/frederic-bastien |
| Mark Dobbin | Founding Partner and Fellow | https://shizune.co/investors/profile/mark-dobbin |
| Nils Herrmann | Stream Lead AgriFood | https://shizune.co/investors/profile/nils-arne-herrmann |

## Similar investors

### Similar industry
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund
- [British Business Investments](https://shizune.co/investors/profile/british-business-investments) — VC Fund
- [White Star Capital](https://shizune.co/investors/profile/white-star-capital) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [BDC Venture Capital](https://shizune.co/investors/profile/bdc-venture-capital) — VC Fund
- [Real Ventures](https://shizune.co/investors/profile/real-ventures) — VC Fund
- [Anges Quebec](https://shizune.co/investors/profile/anges-quebec) — VC Fund

## Featured in investor lists
- [Venture Capital Investors in Canada](https://shizune.co/investors/venture-capital-investors-canada)

## FAQ

### What does Christopher Bissonnette invest in?

Christopher Bissonnette invests primarily in Software, Enterprise Software and Information Technology startups, most often at Seed and Series A stage. Most of the 8 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Christopher Bissonnette's check size?

Christopher Bissonnette typically joins rounds of $653k–$5M at Seed and $15M–$20M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Christopher Bissonnette participates in.

### When did Christopher Bissonnette last invest?

The most recent investment recorded for Christopher Bissonnette closed in Dec 2023. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co